Clinical Trial Update: Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating genetic testing to guide therapy for advanced or metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | Status: RECRUITING